[Informe de investigación] Se espera que el mercado de pruebas de E. coli alcance los 2.527,73 millones de dólares en 2027, frente a los 1.506,95 millones de dólares de 2019; se estima que crecerá a una tasa compuesta anual del 6,8% de 2020 a 2027.
E. coli se realizan para determinar la biotoxicidad en aplicaciones relacionadas con la atención médica, como las ciencias médicas, alimentarias, biológicas y ambientales. E. coli son bacterias oportunistas gramnegativas que pueden causar enfermedades infecciosas transmitidas por los alimentos y el agua, así como intoxicaciones alimentarias. También es responsable de la contaminación del agua que puede provocar enfermedades gastrointestinales crónicas. La bacteria tiene varias ventajas moleculares, lo que la convierte en un organismo modelo de elección en diversas investigaciones biotecnológicas. El crecimiento del mercado de pruebas se atribuye a factores como el aumento de E. coli, crecientes innovaciones de productos y crecientes actividades de investigación. Por otro lado, los desafíos de las pruebas son el factor principal que limita el crecimiento del mercado.
Mercados regionales lucrativos para E. coli Pruebas
Perspectivas del mercado
Aumento de las pruebas de E. coli
Escherichia coli es un gran grupo de bacterias transmitidas por los alimentos, que se encuentran en los alimentos y el medio ambiente, así como en los intestinos de animales y humanos. Aunque la mayoría de los tipos de E coli son inofensivos y ayudan a mantener saludable el tracto digestivo, algunas cepas pueden causar infecciones del tracto, enfermedades respiratorias y neumonía, entre otras. La mayoría de los casos de intoxicación alimentaria y enfermedades infecciosas se deben a E. coli. Por tanto, es fundamental detectar la concentración E. coli en diversos productos. Además de sectores industriales como el farmacéutico, el biotecnológico y el medioambiental, el sector alimentario y ambiental. El sector de bebidas corre un mayor riesgo de contaminación por E coli. Es imperativo para la alimentación y la salud. empresas de bebidas para detectar y monitorear la presencia de la bacteria antes de iniciar la producción, durante el proceso de producción y en los productos finales.
De manera similar, varias empresas farmacéuticas y de biotecnología siguen buenas prácticas de fabricación (GMP) y buenas prácticas de fabricación actuales ( BPFc). La creciente incidencia de enfermedades infecciosas también está llevando al diagnóstico de E. coli en las muestras recogidas de los pacientes. Las regiones en desarrollo, como Asia Pacífico, Medio Oriente y África, y América Latina, tienen una incidencia creciente de enfermedades infecciosas. Por lo tanto, E. coli ha aumentado en los laboratorios de diagnóstico y hospitales de estas regiones. Por ejemplo, según un artículo "Caracterización de STEC y otras E. diarreicas". coli aislado en CHROMagar STEC en un hospital de referencia terciario, Ciudad del Cabo” Publicado en 2018, se identificó la toxina Shiga que produce E. coli (STEC) como patógeno zoonótico emergente. El estudio se llevó a cabo en un hospital de Ciudad del Cabo, Sudáfrica, y identificó que E. coli puede causar insuficiencia renal aguda en niños. Por lo tanto, E. coli se realiza ampliamente en varios sectores, lo que a su vez impulsa el crecimiento de su mercado.
Información tecnológica
Basado en la tecnología, la E. coli el mercado de pruebas se segmenta en anticuerpos monoclonales, dispersión diferencial de luz, diagnóstico molecular, inmunoensayos, cromatografía, citometría de flujo, microgotas de gel y diagnóstico por imágenes. El segmento de anticuerpos monoclonales tuvo la mayor participación de mercado en 2019 debido a las ventajas de estos anticuerpos sobre los anticuerpos policlonales para determinar la presencia de E. coli en las muestras de prueba. Además, este tipo de anticuerpos garantiza una baja reactividad cruzada, una alta especificidad y una excelente estabilidad entre lotes durante la E. coli pruebas. Sin embargo, se estima que el segmento de inmunoensayos registrará la CAGR más alta del mercado durante el período previsto; El crecimiento del mercado para este segmento se atribuye a la mejora esperada en la eficiencia de E. coli gracias a los continuos avances en biotecnología.
Mercado global de pruebas de E. coli, por tecnología: 2019 y 2027
Perspectivas del usuario final
Basado en el usuario final, el E. coli el mercado de pruebas está segmentado en laboratorios comerciales o privados, consultorios médicos, hospitales, laboratorios de salud pública e institutos de investigación académica. El segmento de laboratorios de salud pública tuvo la mayor participación de mercado en 2019. Sin embargo, se estima que el segmento de institutos de investigación académica registrará la CAGR más alta del mercado durante el período de pronóstico.
Perspectivas estratégicas
Las fusiones y adquisiciones son las estrategias más comúnmente adoptadas por las empresas del E. coli, lo que les permite ampliar su presencia global y sus carteras de productos y servicios. Los actores del mercado adoptan la estrategia de lanzamiento de productos para ampliar su base global de clientes, lo que también les permite mantener su marca a nivel mundial.
Mercado global de pruebas de E. coli: Por tecnología
- Anticuerpos monoclonales
- Dispersión diferencial de luz
- Diagnóstico molecular
- Inmunoensayos
- Cromatografía< /li>
- Citometría de flujo
- Microgotas de gel
- Diagnóstico por imágenes
Mercado global de pruebas de E. coli: Por usuario final
- Laboratorios comerciales o privados
- Consultorios médicos
- Hospitales
- Laboratorios de salud pública
- Institutos de Investigación Académica
E. Mercado de pruebas de coli: Por geografía
- América del Norte
- Estados Unidos
- Canadá
- México
< li>Europa - Francia
- Alemania
- Italia
- Reino Unido
- España
- Asia Pacífico (APAC)
- China
- India
- Corea del Sur
- Japón
- Australia
- Medio Oriente y África (MEA)
- Sudáfrica
- Arabia Saudita
- EAU< /li>
- América del Sur y Central
- Brasil
- Argentina
Perfiles de la empresa
- Bio-Rad Laboratories, Inc
- Pro-Lab Diagnostics, Inc.
- Abbott (Alere Inc.)
- IDEXX Laboratories, Inc.
- Meridian Bioscience, Inc.
- BD
- Thermo Fisher Scientific, Inc. .
- CPI Internacional
- Biomerieux Inc.
- Hologic, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Escherichia coli (E. coli) are rod-shaped gram-negative bacteria that are generally available in the food, environment, and intestines of warm-blooded animals. The majority of the E. coli strains are typically harmless to humans. Still, some strains recognized to be the reason for serious some medical complications such as gastrointestinal tract infections, cholecystitis, cholangitis, neonatal meningitis, bacteremia, pneumonia, urinary tract infection (UTI) and regularly spread via polluted food or water. Therefore, it is essential to test samples such as blood, urine, and stool, among others, to identify the cause of diseases. In addition, E. coli testing is majorly done in the food& beverage, environmental industries to prevent food poisoning and the spread of water-borne diseases. E. coli test determines the presence or absence of E. coli in the pharmaceutical and biotechnology industry as it also assists in various researches that prove to be beneficial for human, animal, and plant health.
The growth of E. coli testing market is driven by some key driving factors such as E. coli testing, growing product innovation, and rising research activities are expected to propel the growth of the market. However, testing challenges is the major factor, expected to hinder the market growth during forecast period.
The cost of the E. coli test is widely dependent on the services provider and the reagents used for the test. It also depends upon the tests such as diagnosis or clinical tests, food testing, water testing, and others. The average cost of the E. coli test varies between US$ 30 to US$ 500 and more depending upon the technology used by the service provider.
The List of Companies - E.coli Testing Market
- Bio-Rad Laboratories Inc
- Pro Lab Diagnostics Inc.
- Abbott (Alere Inc.)
- IDEXX Laboratories, Inc.
- Meridian Bioscience, Inc.
- BD
- Thermo Fisher Scientific Inc
- bioMerieux SA
- NEOGEN Corporation
- Hologic, Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Jun 2020
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jun 2020
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2020
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jun 2020
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Jun 2020
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Jun 2020
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Jun 2020
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)